US-Irish firm Medtronic (NYSE: MDT) has entered into a partnership with China-based China Resources Guangdong Pharmaceutical Co., Ltd. (HKG: 3320) at the 7th China International Import Expo (CIIE). The collaboration is aimed at developing minimally invasive surgical medical equipment to enhance patients’ diagnosis and treatment experience.
Focus on GBA Policy and Medical Technology Innovation
The partnership will explore opportunities arising from the “Hong Kong-Macau Drug and Device Access” policy, which is part of the Greater Bay Area (GBA) policy. This policy allows patients to access drugs across Hong Kong, Macau, and various cities in Guangzhou. The collaboration will promote medical technology innovation, accelerate the implementation of innovative products in the Chinese market, and provide excellent medical solutions for the hospital system and patients.- Flcube.com
